Furthermore, miR-96 is one of the 60 miRNAs whose expression most differentiated PCa clinical groups in TCGA-PRAD cohort [9].The current study extends these reports of oncogenic actions of miR-96 to identify the RARγ network as a major biological and clinically relevant target. The gene discussed is RARG; the disease is posterior cortical atrophy.